ECSP099506A - Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos - Google Patents

Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos

Info

Publication number
ECSP099506A
ECSP099506A EC2009009506A ECSP099506A ECSP099506A EC SP099506 A ECSP099506 A EC SP099506A EC 2009009506 A EC2009009506 A EC 2009009506A EC SP099506 A ECSP099506 A EC SP099506A EC SP099506 A ECSP099506 A EC SP099506A
Authority
EC
Ecuador
Prior art keywords
quinoxalinona
quinolinona
derivatives
bacterial agents
anti bacterial
Prior art date
Application number
EC2009009506A
Other languages
English (en)
Inventor
Folkert Reck
Janelle Comita-Prevoir
Mark Cronin
Bolin Geng
Andrew Aydon Godfrey
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39046831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP099506(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ECSP099506A publication Critical patent/ECSP099506A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención se refiere a compuestos de Fórmula (I): y sales farmacéuticamente aceptables de los mismos, a su uso en el tratamiento de infecciones bacterianas y a sus métodos de preparación.
EC2009009506A 2006-12-15 2009-07-09 Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos ECSP099506A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87018106P 2006-12-15 2006-12-15
US96916307P 2007-08-30 2007-08-30

Publications (1)

Publication Number Publication Date
ECSP099506A true ECSP099506A (es) 2009-08-28

Family

ID=39046831

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009506A ECSP099506A (es) 2006-12-15 2009-07-09 Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos

Country Status (17)

Country Link
EP (1) EP2121702A1 (es)
JP (1) JP2010513255A (es)
KR (1) KR20090090385A (es)
AR (1) AR064369A1 (es)
AU (1) AU2007331247B2 (es)
BR (1) BRPI0720236A2 (es)
CA (1) CA2671485A1 (es)
CL (1) CL2007003641A1 (es)
CO (1) CO6190619A2 (es)
EC (1) ECSP099506A (es)
MX (1) MX2009006325A (es)
NO (1) NO20092655L (es)
PE (1) PE20081511A1 (es)
RU (1) RU2009126731A (es)
TW (1) TW200831517A (es)
UY (1) UY30788A1 (es)
WO (1) WO2008071961A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1900732A4 (en) 2005-06-24 2009-11-18 Toyama Chemical Co Ltd NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
US8507478B2 (en) 2008-10-10 2013-08-13 Actelion Pharmaceuticals Ltd. Oxazolidinyl antibiotics
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
CA2813080A1 (en) * 2010-10-04 2012-04-12 British Columbia Cancer Agency Branch Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
EP3672960A2 (en) * 2017-08-21 2020-07-01 Acadia Pharmaceuticals Inc. Compounds, salts thereof and their use for the treatment of diseases
RS67273B1 (sr) 2017-08-21 2025-10-31 Acadia Pharm Inc Jedinjenja, njihove soli i njihova upotreba u lečenju bolesti

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601265A1 (de) * 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
JP5314244B2 (ja) * 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1900732A4 (en) * 2005-06-24 2009-11-18 Toyama Chemical Co Ltd NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF
SG164384A1 (en) * 2006-05-26 2010-09-29 Toyama Chemical Co Ltd Novel heterocyclic compound or salt thereof and intermediate thereof
JP2009539807A (ja) * 2006-06-09 2009-11-19 グラクソ グループ リミテッド 抗菌薬としての置換１−メチル−１ｈ−キノリン−２−オンおよび１−メチル−１ｈ−１，５−ナフチリジン−２−オン
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
NZ573644A (en) * 2006-07-20 2011-09-30 Glaxo Group Ltd Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones

Also Published As

Publication number Publication date
RU2009126731A (ru) 2011-01-20
EP2121702A1 (en) 2009-11-25
PE20081511A1 (es) 2008-12-12
AU2007331247B2 (en) 2011-10-20
WO2008071961A8 (en) 2009-10-22
BRPI0720236A2 (pt) 2013-12-24
CO6190619A2 (es) 2010-08-19
AU2007331247A1 (en) 2008-06-19
MX2009006325A (es) 2009-07-24
TW200831517A (en) 2008-08-01
KR20090090385A (ko) 2009-08-25
WO2008071961A1 (en) 2008-06-19
NO20092655L (no) 2009-09-02
UY30788A1 (es) 2008-07-31
JP2010513255A (ja) 2010-04-30
AR064369A1 (es) 2009-04-01
CA2671485A1 (en) 2008-06-19
CL2007003641A1 (es) 2008-09-22

Similar Documents

Publication Publication Date Title
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
CR11641A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
SV2010003598A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
UY30759A1 (es) Compuestos quimicos
CR20140392A (es) Dihidropirazolonas sustituidas
ECSP099750A (es) Imidazoquinolinas con propiedades inmunomoduladoras
UY31940A (es) Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones
ECSP10010556A (es) Piridinas y pirazinas como inhibidores de pi3k
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
CL2011000917A1 (es) Compuestos derivados de tioamida; sus metodos de preparacion y uso de los compuestos para el tratamiento de enfermedades endoparasitarias.
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
BRPI0507312A (pt) derivados de quinolina para uso como inibidores micobacterianos
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
UY31141A1 (es) Compuestos de piperidina y sus usos
ECSP10010664A (es) Derivados de urea heterocíclicos para el tratamiento de infecciones bacterianas
ECSP109900A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas
UY32856A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
DOP2010000374A (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
UY32694A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UY32316A (es) Derivados de piperidina utiles en el tratamiento de infecciones bacterianas